Literature DB >> 16503326

Update on drug-induced depression in the elderly.

Michael Kotlyar1, Maurice Dysken, David E Adson.   

Abstract

BACKGROUND: Depression is a common disorder in the elderly. Use of certain medications may be a potentially preventable cause of new-onset depression or worsening of established depression.
OBJECTIVE: This paper reviews recent publications evaluating medications commonly used in the elderly as potential causes of depressive symptoms.
METHODS: Relevant articles examining the association between medication use and symptoms of depression were identified through searches of MEDLINE (1996-March 2005) and International Pharmaceutical Abstracts (1996-March 2005) using the MeSH heading depression and the subheading chemically induced. Included articles were limited to those that discussed medications commonly used in the elderly and that employed a rigorous study design.
RESULTS: A wide variety of medications have been implicated as potential causes of depressive symptoms in numerous reports, although many of these reports relied on data obtained from observational rather than experimental studies. The most extensively studied agents include anti hypertensives, lipid-lowering drugs, and selective estrogen-receptor modulators. The data on antihypertensive agents were contradictory; however, most studies found no association between use of the newer lipid-lowering drugs (statins) or selective estrogen-receptor modulators and the emergence of depressive symptoms. Corticosteroids, although not studied recently, generally have been associated with depressive symptoms in the older literature.
CONCLUSIONS: The recent data evaluating whether medications can induce or worsen symptoms of depression are largely contradictory. This reflects a relative lack of controlled studies of this association and the difficulties in determining whether depressive symptoms are caused by a particular medication or by other factors. Nonetheless, when new or worsening symptoms of depression occur, medications should be considered a potential cause and withdrawn as appropriate. Nonpharmacologic and/or pharmacologic treatment is indicated for those whose depressive symptoms do not resolve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16503326

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  7 in total

Review 1.  Potentially inappropriate medications in the elderly: a comprehensive protocol.

Authors:  Suzana Mimica Matanović; Vera Vlahovic-Palcevski
Journal:  Eur J Clin Pharmacol       Date:  2012-02-24       Impact factor: 2.953

2.  The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

3.  Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns.

Authors:  Elisa Martín-Merino; Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis A García-Rodriguez
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

Authors:  Liang Feng; Chay-Hoon Tan; Reshma A Merchant; Tze-Pin Ng
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  [Psychopharmacotherapy in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-11       Impact factor: 0.840

6.  Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms.

Authors:  Dorothy Keine; Mark Zelek; John Q Walker; Marwan N Sabbagh
Journal:  Neurol Ther       Date:  2019-03-21

7.  A survey of pharmacists' perceptions of the adequacy of their training for addressing mental health-related medication issues.

Authors:  Courtney S Goodman; Tammy J Smith; Joseph M LaMotte
Journal:  Ment Health Clin       Date:  2018-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.